Investigating The Experiences of Patients In Immunotherapy Clinical Trials

It has been observed before that participation in medical trials has been in favor of specific demographic groups. But research pointing out which trial attributes impact participation positively or negatively is sparse.

This study invites various participants to collect more data on their immunotherapy clinical experiences. The goal is to know which factors always limit how patients participate or complete the medical study they are first interested in.

The data obtained in the trial will be assessed through a variety of demographic lenses to discover patterns that might improve the experience of immunotherapy patients in the future.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Immunotherapy Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient has self-identified as planning to participate in an interventional clinical trial using immunotherapy
Patient has been diagnosed with a type of cancer
Patient is a minimum of 18 years or older

Exclusion criteria

Patient has an ECOG score of 4 or higher
Patient is not able to provide consistent digital reporting as per study requirements
Patient does not complete Informed Consent Form

Treatment and study plan

Primary outcomes

Number of patients who decide to enroll in an immunotherapy clinical trial

Time frame: 3 months
Rate of patients who remain in immunotherapy clinical trial to trial completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

(415) 900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

An Observational Study Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Jun 28, 2022
Registry last updated: Jan 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting